Related Experiment Video
Updated: Jul 11, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Pathophysiology of spontaneous coronary artery dissection: hematoma, not thrombus
Aleksandra Djokovic1,2, Gordana Krljanac1,3, Predrag Matic1,4
1Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Insights
Spontaneous coronary artery dissection (SCAD) affects 1.7%-4% of acute coronary syndrome cases, especially young women. This review covers SCAD
Area of Science:
- Cardiology
- Vascular Biology
- Medical Reviews
Background:
- Spontaneous coronary artery dissection (SCAD) represents a significant cause of acute coronary syndrome (ACS), particularly in younger women.
- SCAD accounts for 1.7%-4% of ACS cases, highlighting its clinical relevance.
- Distinguishing SCAD from atherothrombotic coronary disease and determining optimal treatment remain challenging.
Purpose of the Study:
- To consolidate current understanding of SCAD pathophysiology.
- To explore potential therapeutic strategies for SCAD.
- To provide a contemporary review of SCAD knowledge.
Main Methods:
- Literature review of recent studies on SCAD.
- Analysis of known arteriopathies and triggers associated with SCAD.
- Synthesis of information on diagnostic and therapeutic approaches.
Main Results:
- SCAD has diverse underlying causes and triggers, with variable prevalence.
- The etiology of SCAD often remains unidentified.
- Current therapeutic approaches for SCAD are still evolving.
Conclusions:
- Further research is needed to fully elucidate SCAD pathophysiology.
- Developing standardized diagnostic and therapeutic guidelines for SCAD is crucial.
- Increased awareness and understanding of SCAD are essential for improved patient outcomes.
Abstract:
Spontaneous coronary artery dissection (SCAD) accounts for 1.7%-4% of all acute coronary syndrome presentations, particularly among young women with an emerging awareness of its importance. The demarcation of acute SCAD from coronary atherothrombosis and the proper therapeutic approach still represents a major clinical challenge. Certain arteriopathies and triggers are related to SCAD, with high variability in their prevalence, and often, the cause remains unknown. The objective of this review is to provide contemporary knowledge of the pathophysiology of SCAD and possible therapeutic solutions.
More Related Videos
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Peripheral Artery Disease I: Introduction

